NuGene International Return On Asset vs. Price To Earning

NUGN Stock  USD 0.01  0  25.00%   
Taking into consideration NuGene International's profitability measurements, NuGene International may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess NuGene International's ability to earn profits and add value for shareholders.
For NuGene International profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NuGene International to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NuGene International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NuGene International's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NuGene International over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between NuGene International's value and its price as these two are different measures arrived at by different means. Investors typically determine if NuGene International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NuGene International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

NuGene International Price To Earning vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining NuGene International's current stock value. Our valuation model uses many indicators to compare NuGene International value to that of its competitors to determine the firm's financial worth.
NuGene International is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in price to earning category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value NuGene International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NuGene International's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

NuGene Price To Earning vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

NuGene International

Return On Asset

 = 

Net Income

Total Assets

 = 
-9.44
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

NuGene International

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
(0.03) X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

NuGene Price To Earning Comparison

NuGene International is currently under evaluation in price to earning category among its peers.

NuGene International Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in NuGene International, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NuGene International will eventually generate negative long term returns. The profitability progress is the general direction of NuGene International's change in net profit over the period of time. It can combine multiple indicators of NuGene International, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Livento Group, Inc. engages in the film and television production activities. Livento Group, Inc. was incorporated in 2013 and is based in New York, New York. Nugene International operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.

NuGene Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on NuGene International. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NuGene International position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NuGene International's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in NuGene International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module

Use Investing Themes to Complement your NuGene International position

In addition to having NuGene International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aggressive Defence Thematic Idea Now

Aggressive Defence
Aggressive Defence Theme
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in NuGene Pink Sheet

To fully project NuGene International's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of NuGene International at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include NuGene International's income statement, its balance sheet, and the statement of cash flows.
Potential NuGene International investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although NuGene International investors may work on each financial statement separately, they are all related. The changes in NuGene International's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NuGene International's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.